ID: ALA2437413

Max Phase: Preclinical

Molecular Formula: C9H12N4O4

Molecular Weight: 240.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)/[N+]([O-])=N/OCc1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C9H12N4O4/c1-11(2)13(16)10-17-7-8-3-5-9(6-4-8)12(14)15/h3-6H,7H2,1-2H3/b13-10-

Standard InChI Key:  BTNWVRAGIWVUPG-RAXLEYEMSA-N

Associated Targets(Human)

DLD-1 17511 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 240.22Molecular Weight (Monoisotopic): 240.0859AlogP: 1.47#Rotatable Bonds: 5
Polar Surface Area: 94.04Molecular Species: ACIDHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.64CX Basic pKa: CX LogP: -1.33CX LogD: 0.70
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.34Np Likeness Score: -1.01

References

1. Sharma K, Sengupta K, Chakrapani H..  (2013)  Nitroreductase-activated nitric oxide (NO) prodrugs.,  23  (21): [PMID:24050886] [10.1016/j.bmcl.2013.08.066]

Source